Appropriate design and outcome measures in multiple sclerosis clinical trials.
Greenstein
J I
JI
D006801:Humans; D000068556:Interferon beta-1a; D000068576:Interferon beta-1b; D016899:Interferon-beta / Q000627:therapeutic use; D009103:Multiple Sclerosis / Q000628:therapy*; D011994:Recombinant Proteins / Q000627:therapeutic use; D012107:Research Design; D016896:Treatment Outcome
D011994:Recombinant Proteins; D000068576:Interferon beta-1b; D016899:Interferon-beta; D000068556:Interferon beta-1a